Page 87 - Journal of Special Operations Medicine - Spring 2014
P. 87

Effects of Intraosseous and Intravenous Administration
                               of Hextend  on Time of Administration and
                                                ®
                                      Hemodynamics in a Swine Model



                      Don Johnson, RN, PhD; James Dial, MSN; Jake Ard, BSN; Timothy Yourk, BSN;
              Ellen Burke, BSN; Craig Paine, BSN; Brian Gegel, CRNA, DNAP; James Burgert, CRNA, DNAP





              ABSTRACT
              Introduction: The military recommends that a 500mL bo-  hypovolemic shock. Numerous studies have found that
              lus of Hextend  be administered via an intravenous (IV)   IO vascular access is an established rapid, safe, and ef-
                          ®
              18-gauge needle or via an intraosseous (IO) needle for   fective alternative to peripheral intravenous (IV) drug
              patients in hypovolemic shock. Purposes: The purposes   and fluid delivery. Also, studies have demonstrated that
              of this study were to compare the time of administration   IO needles can be quickly inserted.  Additionally, some
                                                                                               5
              of Hextend and the hemodynamics of IV and IO routes   studies show that serum pharmacologic concentrations
              in a Class II hemorrhage swine model. Methods: This was   for medications administered through IO sites have been
              an experimental study using 27 swine. After 30% of their   equivalent to those administered through traditional IV
              blood volume was exsanguinated, 500mL of Hextend   lines.  For example, Van Hoff et al. demonstrated that
                                                                     6,7
              was administered IV or IO, but not to the control group.   there were no statistically significant differences be-
              Hemodynamic data were collected every 2 minutes until   tween IO and IV administration of morphine sulfate for
              administration was complete. Results: Time for adminis-  several pharmacokinetic parameters.
                                                                                                8
              tration was not significant (p = .78). No significant dif-
              ferences existed between the IO and IV groups relative to   IO infusions have been used in treating the entire spec-
              hemodynamics (p > .05), but both were significantly dif-  trum of adult trauma encountered in military casualties
              ferent than the control group (p < .05). Conclusions: The   including hemorrhage, traumatic injury, dehydration,
              IO route is an effective method of administering Hextend.   cardiovascular collapse, and burns. 9,10  However, few
                                                                 studies have examined whether there are differences
              Keywords:  hemorrhage, shock, Hextend ; hetastarch,   in IO and IV administration of medications or fluids
                                                  ®
              battlefield                                        in emergency scenarios. Cameron et al. compared pe-
                                                                 ripheral to central circulation delivery times between IO
                                                                 and IV injection using a radionucleotide technique in
                                                                 normovolemic and hypovolemic canines and found no
              Introduction
                                                                 difference.  Spivey et al. investigated the use of sodium
                                                                          11
              Uncontrolled hemorrhage is the leading cause of prevent-  bicarbonate infusion in a swine model of cardiac arrest
              able death both in the military and in civilian trauma.   and found the IO route was equivalent to, if not better
              Historically, approximately 20% of combat casualties   than, peripheral intravenous infusion to increase blood
              were killed in action with hemorrhage as the major cause   pH.  Warren et al. compared infusion rates of normal
                                                                    12
              of death.  When a patient is in hypovolemic shock, it is   saline through different IO infusion sites and at different
                     1–4
              essential to establish rapid and reliable vascular access.   infusion pressures in both normovolemic and hypovole-
              Often, in this scenario, the patient’s veins have collapsed,   mic piglets. They concluded that infusions via the vari-
              preventing vascular access and making the procedure not   ous IO sites were similar to IV infusions. 13
              only difficult but very time consuming. Furthermore, the
              austere far-forward battlefield presents many additional   The optimal fluid strategy for the early treatment of
              environmental and tactical obstacles such as low light-  trauma patients who are in hypovolemic shock remains
              ing to military personnel attempting to establish vascular   highly debated. However, the U.S. Military’s Committee
              access. This is complicated with the potential of mass   on Tactical Combat Casualty Care (C-TCCC), the group
              casualties. The combination of these factors may lead to   responsible for guidelines in the management of wounded
              excessive delay in obtaining vascular access, resuscitation   military personnel, recommends gaining  vascular access
              and subsequent loss of life. The intraosseous (IO) route   with an 18-gauge IV. If an IV is not  obtainable, they rec-
              may be an effective and rapid method in gaining vascu-  ommend the use of an IO route. The CTCCC further
              lar access for the purpose of resuscitation for patients in   recommends a 500mL bolus of Hextend  that can be
                                                                                                     ®


                                                              79
   82   83   84   85   86   87   88   89   90   91   92